Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection

Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection

The determinants of hepatitis C virus (HCV) viral load remain incompletely understood and may differ in females, who are relatively protected from the consequences of HCV infection during their reproductive years. We aimed to evaluate how age affects the relationship between sex and viral load. <...

Full description

Saved in:

Bibliographic Details
Main Authors:	Andrea Magri, Giulia Francesca Manfredi, Carlo Smirne, Silvia Pigni, Michela Emma Burlone, Mattia Bellan, Nicole Vercellino, Rosalba Minisini, Mario Pirisi
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Viruses
Subjects:	hepatitis C HCV age sex viral load HCV genotype
Online Access:	https://www.mdpi.com/1999-4915/17/1/21
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative evaluation of APRI and MELD scores in the prediction of complications of chronic hepatitis in patients infected with hepatitis B or C viruses in Lubumbashi, democratic republic of Congo
by: Arsène Kabamba-Tshikongo, et al.
Published: (2025-02-01)

Role of Interleukin-28B in clearance of HCV in acute and chronic hepatitis patients in Kirkuk city
by: Muhannad Abdullah Alazzawy
Published: (2018-07-01)

A single-site randomized controlled trial of partner navigation to HCV treatment for people who inject drugs: a study protocol for the You’re Empowered for Treatment Initiation (YETI) partner trial
by: Meghan D. Morris, et al.
Published: (2025-01-01)

Dysregulation in the microbiota by HBV and HCV infection induces an altered cytokine profile in the pathobiome of infection
by: Marcos Daniel Mendes Padilha, et al.
Published: (2025-01-01)

Infection with hepatitis C virus as a cause of cirrhosis – case study
by: Lidia Sierpińska, et al.
Published: (2025-01-01)

Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort
by: Antoanela Curici, et al.
Published: (2025-01-01)

Assessment of Some Heavy Metals and Trace Elements in a Sample of Patients with Viral Hepatitis in Baghdad
by: Najlaa Fattah-Allah Rasheed, et al.
Published: (2022-09-01)

Genotype 3 is linked to worse liver disease progression in hepatitis C patients even after SVR following DAA therapy
by: Xiping Ran, et al.
Published: (2025-02-01)

Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt
by: Ahmed A. Ali, et al.
Published: (2025-01-01)

Prevalence of viral hepatitis B and C infection and associated factors among pregnant women in southeast Ethiopia: community-based crossectional study
by: Nuruzelam Mohammed, et al.
Published: (2025-02-01)

Hepatitis B prevalence in an endemic area of hepatitis C virus: A population-based study implicated in hepatitis elimination in Thailand
by: Nawarat Posuwan, et al.
Published: (2024-12-01)

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients
by: Ana Virseda-Berdices, et al.
Published: (2025-01-01)

HCV and HIV co-infection among people who inject drugs in Vietnam
by: Vu Toan THINH, et al.
Published: (2020-12-01)

Towards an HCV vaccine: an overview of the immunization strategies for eliciting an effective B-cell response
by: Gabriel L. Costa, et al.
Published: (2025-12-01)

Prevalence of hepatitis C virus antibodies and associated risks among residents in long-term assisted living facilities and shelters in Latvia
by: Ieva Tolmane, et al.
Published: (2024-11-01)

Molecular-genetic pathways of hepatitis C virus regulation of the expression of cellular factors PREB and PLA2G4C, which play an important role in virus replication
by: E. L. Mishchenko, et al.
Published: (2023-12-01)

Viral hepatitis B epidemiology in Sakha republic (Yakutia)
by: S. I. Semenov, et al.
Published: (2015-09-01)

Synthesis of some benzimidazole derivatives endowed with 1,2,3-triazole as potential inhibitors of hepatitis C virus
by: Youssif Bahaa G. M., et al.
Published: (2016-06-01)

Impact of interferon-free regimens in patients with chronic HCV and successfully ablated HCC
by: Amr Maged Mahmoud Rasheed, et al.
Published: (2025-02-01)

Treatment of HCV infection in patients with steatotic liver disease
by: Robert Flisiak, et al.
Published: (2024-07-01)

Asian Perspective on Hepatitis B Virus and Hepatitis C Virus Elimination
by: Apichat Kaewdech, et al.
Published: (2024-12-01)

Prevalence of Hepatitis C Virus Among Hospitalized Patients in a Tertiary Hospital in Italy: The Basis for a National Screening Assessment Model?
by: Giulia Morsica, et al.
Published: (2025-01-01)

Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
by: I. A. Goncharova, et al.
Published: (2023-03-01)

Real-world effectiveness of sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir against genotype 3 hepatitis C virus infection: a systematic review and meta-analysis
by: Liwei Zhuang, et al.
Published: (2025-02-01)

Oxidative stress in viral hepatitis
by: Huseyin Erdal, et al.
Published: (2024-04-01)

Long-term results of antiviral therapy in patients with chronic hepatitis C with sustained virologic response
by: T. M. Ignatova, et al.
Published: (2013-09-01)

Hepatitis C Virus–Pediatric and Adult Perspectives in the Current Decade
by: Nanda Kerkar, et al.
Published: (2024-12-01)

Gallbladder Wall Thickness as a Non-Invasive Tool for Prediction of Esophageal Varices in Patients with Hepatitis C Related Chronic Liver Disease
by: Munir Ahmed, et al.
Published: (2025-02-01)

Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk
by: Núria Granel, et al.
Published: (2025-02-01)

The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Novel Polymorphism in a Promoter of MBL2 Gene Result in Lower MBL Expression in Chronic Infection Caused by HCV
by: Paywast Jamal Jalal
Published: (2020-12-01)

Prognostic assessment of early-stage liver cirrhosis induced by HCV using an integrated model of CX3CR1-associated immune infiltration genes
by: Haozheng Cai, et al.
Published: (2025-01-01)

Cytomegalovirus Genetic Diversity and Evolution: Insights into Genotypes and Their Role in Viral Pathogenesis
by: Cristina Venturini, et al.
Published: (2025-01-01)

Bayesian Analysis of Complex Mutations in HBV, HCV, and HIV Studies
by: Bing Liu, et al.
Published: (2019-09-01)

Residual HCV-RNA and Elevated Platelet-to-Lymphocyte Ratio Predict Poor Long-Term Outcomes in Patients with Chronic Hepatitis C After Treatment
by: Anna Wróblewska, et al.
Published: (2024-12-01)

Observational pilot using a Data to Care intervention strategy to promote HCV re-engagement and cure for persons with HIV/HCV co-infection who are out of care
by: Maximilian Wegener, et al.
Published: (2025-01-01)

Cognitive Impairments in Viral Hepatitis Patients: Causes, Manifestations, and Impact on Quality of Life
by: Tatyana Vasiliyevna Polukchi
Published: (2025-01-01)

Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C
by: V. T. Ivashkin, et al.
Published: (2023-06-01)

Treatment of end-stages of liver disease in outcome of persistent hepatitis C virus infection at deficiency of donor organs
by: Ye. N. German, et al.
Published: (2011-03-01)

Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b)
by: P. O. Bogomolov, et al.
Published: (2018-08-01)